(WEED) Roundhill Cannabis - Ratings and Ratios
Cannabis, Hemp, Marijuana, CBD, Seeds, Fibers
Description: WEED Roundhill Cannabis
The Roundhill Cannabis ETF (BATS:WEED) is an actively managed exchange-traded fund that focuses on the cannabis and hemp industry by investing in equity securities and total return swaps. The funds primary objective is to provide exposure to the cannabis ecosystem, which includes companies and REITs that generate a significant portion of their revenue from or invest heavily in cannabis and hemp-related activities.
The ETFs investment strategy is centered around investing at least 80% of its net assets in equity securities, such as common stock and depositary receipts, of companies that derive a substantial portion of their revenue from the cannabis industry. This non-diversified fund is designed to capitalize on the growth potential of the cannabis market, which is expected to continue expanding as more countries and states legalize cannabis for medical and recreational use.
From a technical analysis perspective, the current price of WEED is $10.82, which is below its 20-day and 50-day simple moving averages (SMA) of $11.70 and $11.10, respectively. This indicates a potential downtrend in the short term. However, the Average True Range (ATR) of 0.69, representing a 6.39% volatility, suggests that the ETFs price can fluctuate significantly. Given the 52-week high and low prices of $35.81 and $9.18, respectively, the current price is near the lower end of its recent trading range.
Considering the technical and fundamental data, a forecast for WEED can be made. With the current AUM of $3.82M USD, the ETF has a relatively small asset base, which may impact its liquidity and ability to attract larger investors. However, the actively managed nature of the fund allows for flexibility in responding to market changes. Given the current technical indicators and the fundamental data, a potential price target for WEED could be around $12.50 in the short term, representing a 15% increase from the current price. This forecast is based on the assumption that the cannabis industry will continue to grow and that the ETFs investment strategy will be effective in capturing this growth. However, its essential to note that the cannabis industry is highly volatile and subject to regulatory risks, which can impact the ETFs performance.
Additional Sources for WEED ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
WEED ETF Overview
Market Cap in USD | 4m |
Category | Miscellaneous Sector |
TER | 0.40% |
IPO / Inception | 2022-04-19 |
WEED ETF Ratings
Growth Rating | -69.5 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -71.9 |
Analysts | - |
Fair Price Momentum | 6.45 USD |
Fair Price DCF | - |
WEED Dividends
Currently no dividends paidWEED Growth Ratios
Growth Correlation 3m | -25.8% |
Growth Correlation 12m | -95.5% |
Growth Correlation 5y | -66.2% |
CAGR 5y | -46.64% |
CAGR/Max DD 5y | -0.53 |
Sharpe Ratio 12m | -0.85 |
Alpha | -76.72 |
Beta | 0.384 |
Volatility | 62.81% |
Current Volume | 20.4k |
Average Volume 20d | 12.4k |
As of July 06, 2025, the stock is trading at USD 10.06 with a total of 20,400 shares traded.
Over the past week, the price has changed by +7.23%, over one month by -1.14%, over three months by +6.92% and over the past year by -67.93%.
No, based on ValueRay´s Analyses, Roundhill Cannabis (BATS:WEED) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -69.49 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WEED is around 6.45 USD . This means that WEED is currently overvalued and has a potential downside of -35.88%.
Roundhill Cannabis has no consensus analysts rating.
According to our own proprietary Forecast Model, WEED Roundhill Cannabis will be worth about 7.2 in July 2026. The stock is currently trading at 10.06. This means that the stock has a potential downside of -28.73%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7.2 | -28.7% |